Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Esophageal Squamous Cell Carcinoma
×
Panitumumab
×
Clear all
Filters
3
NCT01627379
2018-03-02
POWER
AIO-Studien-gGmbH
Phase 3
Terminated
300 enrolled